Testing the effect of anti-tobacco message framing on polytobacco use in lesbian, gay, bisexual, and transgender young adults
Project Number4R00CA260718-02
Former Number4K99CA260718-02
Contact PI/Project LeaderPATTERSON, JOANNE G
Awardee OrganizationOHIO STATE UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY
Polytobacco use, defined as concurrent use of more than one tobacco product including electronic nicotine
delivery systems (ENDS), is rising and high in lesbian, gay, bisexual, and transgender (LGBT) young adults (YA).
Between 22-40% of LGBT YA (vs 12-21% of non-LGBT YA) report past 30-day polytobacco use, and LGBT YA
are less likely to perceive tobacco use as harmful. Low risk perceptions may reinforce tobacco use and widen
existing disparities. The Food and Drug Administration (FDA) Center for Tobacco Products (CTP) is mandated
educate the public about tobacco product risks, yet no evidence describes how to effectively frame anti-
polytobacco risk communications. The proposed training objectives are for the applicant to develop advanced
skills in health communication science; bio-behavioral methods, including psychophysiological measurement;
and randomized controlled trials. These skills will be used to determine effective communication of polytobacco
use risks to at-risk LGBT YA. This proposal directly supports the FDA’s mandate to educate the public by
addressing the research priority area of Communications. While studies indicate that antitobacco
communications can successfully increase public knowledge about tobacco use risks, there are limitations to the
extant literature, as follows: (1) While strategies for effective risk communication are well-established, less is
known about how to frame behavioral choices (e.g., total tobacco cessation vs switching to ENDS) to increase
tobacco risk perceptions and intentions to quit in polytobacco users. (2) Antitobacco campaigns often leverage
cultural targeting, a broadly supported but costly communications strategy, to increase at-risk population
engagement. No studies have experimentally tested the effectiveness of LGBT culturally targeted vs non-
targeted anti-tobacco messages. (3) Mobile multimedia messaging has been used to disseminate smoking
cessation communications and may be feasible for distributing anti-polytobacco messages to LGBT YA, but this
has not been investigated. Using formative and summative evaluation, the applicant will address these gaps with
three Specific Aims: (1) Identify absolute and relative risk anti-polytobacco messages that effectively
communicate polytobacco risks to YA; (2) Determine the effects of cultural targeting on LGBT YA polytobacco
users’ attention to anti-polytobacco messages and perceived effectiveness; (3b) Assess the feasibility of
delivering MMS anti-polytobacco messages developed in Aims 1 and 2 to LGBT YA via texting; and (3b) Estimate
effect sizes of exposure to anti-polytobacco messages on risk perceptions and tobacco use over time. These
aims support the National Cancer Institute’s (NCI) tobacco control research priority to reduce tobacco disparities
by determining effective antitobacco message framing and cultural targeting to increase polytobacco risk
perceptions and reduce tobacco use in an at-risk population, LGBT YA. Findings will provide public health
officials, NCI, and the FDA CTP critical information about messages and digital media that may be leveraged in
national health communications to reduce poly-tobacco use in at-risk populations.
Public Health Relevance Statement
PROJECT NARRATIVE
Between 22-40% of lesbian, gay, bisexual, and transgender (LGBT) young adults are polytobacco users,
meaning they concurrently use multiple nicotine and tobacco products, and low tobacco risk perceptions may be
an influencing factor. The proposed study uses crowdsourced (Aim 1), in-laboratory (Aim 2), and Phase I
randomized controlled trial (Aim 3) studies to determine effective message framing and targeting to communicate
polytobacco use risk to LGBT young adult polytobacco users, and if exposure to anti-polytobacco
communications delivered via text messaging reduces tobacco use in this population. Findings will provide public
health officials, the National Cancer Institute, and the Food and Drug Administration critical information about
optimal anti-polytobacco message framing and digital dissemination strategies that may be leveraged in national
health communications.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdultAffectAreaAttentionBehaviorBehavioralCommunicationDataEffectivenessElectronic Nicotine Delivery SystemsEvaluationExposure toFutureGalvanic Skin ResponseGoalsHarm ReductionHealthKnowledgeLaboratoriesLesbian Gay Bisexual TransgenderLifeLiteratureMeasurementMeasuresMethodsMultimediaNational Cancer InstituteNicotinePatient Self-ReportPersonsPhasePopulationPopulations at RiskPsychophysiologyPublic HealthRandomized Controlled TrialsRelative RisksReportingResearch PriorityRiskRisk BehaviorsScienceSmokerTestingTextText MessagingTimeTobaccoTobacco Control ResearchTobacco Use CessationTobacco useTrainingUnited States Food and Drug Administrationbiobehaviorcigarette smokingcostcrowdsourcingcultural valuesdigitaldigital mediadissemination strategyeffectiveness testinghealth communicationpolytobaccopolytobacco usepreventreduce tobacco userisk perceptionskillssmoking cessationtobacco productsuptakevisual trackingyoung adult
No Sub Projects information available for 4R00CA260718-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 4R00CA260718-02
Patents
No Patents information available for 4R00CA260718-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 4R00CA260718-02
Clinical Studies
No Clinical Studies information available for 4R00CA260718-02
News and More
Related News Releases
No news release information available for 4R00CA260718-02
History
No Historical information available for 4R00CA260718-02
Similar Projects
No Similar Projects information available for 4R00CA260718-02